Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
Top Cited Papers
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (9), 1904-1913
- https://doi.org/10.1111/j.1538-7836.2007.02663.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pathogenesis of haemophilic arthropathyHaemophilia, 2006
- Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitorsHaemophilia, 2006
- Prophylactic treatment with FEIBA of a haemophilia A patient with inhibitor: what are the costs, what are the benefits?Haemophilia, 2005
- Prophylactic recombinant factor VIIa in haemophilia patients with inhibitorsHaemophilia, 2005
- Prevention of bleeds in hemophilia patients with inhibitors: Emerging data and clinical directionAmerican Journal of Hematology, 2004
- Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study GroupBlood, 2003
- NovoSeven® in immune tolerance therapyBlood Coagulation & Fibrinolysis, 2000
- Resource utilisation in haemophiliacs treated in Europe: Results from the European Study on Socioeconomic Aspects of Haemophilia CareHaemophilia, 1998
- Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysisThe Journal of Pediatrics, 1996
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994